The global angiotensin receptor antagonists market is expanding as healthcare systems respond to the growing burden of hypertension, cardiovascular disorders, and kidney-related complications. Increasing diagnosis rates, wider access to chronic disease therapies, and continued physician adoption of established receptor-targeted medicines are supporting market development across developed and...